However, ALKBH5 attenuates YTHDF2-mediated downregulation of oncogenic drivers such as SOX2, SMAD7, and MYC, contributing to the progression of aggressive lung cancer with KRAS mutation/LKB1 loss (234). The gene discussed is YTHDF2; the disease is lung cancer.